Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Zevia
ZVIA
$105M
| $290K | ﹤0.01% |
+25,149
| New | +$334K |
|
3277
Velocity Financial
VEL
$720M
| $289K | ﹤0.01% |
21,927
| – | – |
|
|
PPTA
3278
Perpetua Resources
PPTA
$3.18B
| $283K | ﹤0.01% |
56,806
| – | – |
|
|
RAIN
3279
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $283K | ﹤0.01% |
18,897
| – | – |
|
|
HOOK
3280
DELISTED
HOOKIPA Pharma
HOOK
| $281K | ﹤0.01% |
4,769
| – | – |
|
3281
Neuropace
NPCE
$513M
| $277K | ﹤0.01% |
17,448
| – | – |
|
|
AOMR
3282
Angel Oak Mortgage REIT
AOMR
$208M
| $276K | ﹤0.01% |
+16,299
| New | +$290K |
|
3283
Laird Superfood
LSF
$51M
| $276K | ﹤0.01% |
14,422
-11,161
| -44% | -$256K |
|
3284
Summit Therapeutics
SMMT
$12.1B
| $276K | ﹤0.01% |
55,033
+7,385
| +15% | +$53K |
|
|
JOAN
3285
DELISTED
JOANN, Inc. Common Stock
JOAN
| $275K | ﹤0.01% |
24,610
-4,339
| -15% | -$59.8K |
|
|
STON
3286
DELISTED
StoneMor Inc.
STON
| $273K | ﹤0.01% |
110,246
| – | – |
|
|
KLDO
3287
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $271K | ﹤0.01% |
49,594
-90,884
| -65% | -$564K |
|
3288
Quantum-Si Incorporated
QSI
$179M
| $268K | ﹤0.01% |
+32,018
| New | +$315K |
|
3289
Biomea Fusion
BMEA
$93.5M
| $263K | ﹤0.01% |
21,940
| – | – |
|
|
ALPN
3290
DELISTED
Alpine Immune Sciences Inc
ALPN
| $263K | ﹤0.01% |
24,623
-4,137
| -14% | -$38.1K |
|
|
MAPS
3291
DELISTED
WM TECHNOLOGY INC A
MAPS
| $261K | ﹤0.01% |
+18,000
| New | +$260K |
|
3292
Biodesix
BDSX
$256M
| $259K | ﹤0.01% |
1,570
-497
| -24% | -$94.3K |
|
3293
Cricut
CRCT
$1.25B
| $258K | ﹤0.01% |
9,353
+3,094
| +49% | +$101K |
|
3294
indie Semiconductor
INDI
$805M
| $258K | ﹤0.01% |
+20,931
| New | +$204K |
|
3295
RxSight
RXST
$293M
| $256K | ﹤0.01% |
+20,178
| New | +$278K |
|
3296
Rallybio
RLYB
$87M
| $254K | ﹤0.01% |
+1,806
| New | +$212K |
|
3297
Hamilton Beach Brands
HBB
$445M
| $246K | ﹤0.01% |
15,673
-2,118
| -12% | -$38K |
|
3298
Ardelyx
ARDX
$982M
| $242K | ﹤0.01% |
183,262
-25,750
| -12% | -$68.8K |
|
3299
Target Hospitality
TH
$1.66B
| $242K | ﹤0.01% |
64,788
-107,427
| -62% | -$395K |
|
3300
Victory Capital Holdings
VCTR
$6.99B
| $241K | ﹤0.01% |
6,857
| – | – |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.